In contrast to investigations describing the pro-angiogenic outcome of MSCs (Zhang et al., 2013; Li et al., 2016), the anti-tumor activity of MSCs via inhibition of tumor angiogenesis has also been documented. A review https://harleymuxg954663.tinyblogging.com/mesenchymal-stem-cells-therapy-cost-an-overview-74368881